Published in Proc Natl Acad Sci U S A on February 01, 1986
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol (1988) 3.21
Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J Virol (1987) 3.16
Expression of hepatitis B viral core region in mammalian cells. Mol Cell Biol (1986) 3.14
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol (1993) 2.12
Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Acad Sci U S A (1989) 2.10
In vivo phosphorylation and protein analysis of hepatitis B virus core antigen. J Virol (1987) 1.95
Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.88
Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc Natl Acad Sci U S A (1990) 1.54
Hepatitis B virus (HBV) promoters are regulated by the HBV enhancer in a tissue-specific manner. J Virol (1989) 1.49
Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. Mol Cell Biol (1989) 1.39
Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol (1991) 1.28
A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A (1990) 1.27
Differentiation-specific transcriptional regulation of the hepatitis B virus large surface antigen gene in human hepatoma cell lines. J Virol (1990) 1.26
The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter. Mol Cell Biol (1991) 1.26
A new enhancer element, ENII, identified in the X gene of hepatitis B virus. J Virol (1990) 1.23
Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice. J Virol (1988) 1.19
X-region-specific transcript in mammalian hepatitis B virus-infected liver. J Virol (1988) 1.16
The S promoter of hepatitis B virus is regulated by positive and negative elements. Mol Cell Biol (1988) 1.13
Detection and mapping of spliced RNA from a human hepatoma cell line transfected with the hepatitis B virus genome. Proc Natl Acad Sci U S A (1989) 1.13
The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location. J Virol (1988) 1.04
Complex regulation of transcription from the hepatitis B virus major surface antigen promoter in human hepatoma cell lines. J Virol (1991) 1.02
Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J Virol (1989) 1.01
Regulation of transcription from the hepatitis B virus major surface antigen promoter by the Sp1 transcription factor. J Virol (1992) 0.99
Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice. J Virol (1992) 0.99
Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. J Virol (2000) 0.98
Characterization of hepatitis B virus major surface antigen gene transcriptional regulatory elements in differentiated hepatoma cell lines. J Virol (1989) 0.95
Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol (2004) 0.95
Hepatitis B virus suppresses expression of human beta-interferon. Proc Natl Acad Sci U S A (1988) 0.92
Free and integrated forms of hepatitis B virus DNA in human hepatocellular carcinoma cells (PLC/342) propagated in nude mice. J Virol (1987) 0.91
Replicative intermediate of hepatitis B virus in transfected murine fibroblasts. J Virol (1987) 0.86
Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma. J Virol (2016) 0.76
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
Promoter sequences of eukaryotic protein-coding genes. Science (1980) 19.96
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42
Hybridization of denatured RNA transferred or dotted nitrocellulose paper. Methods Enzymol (1983) 14.71
Hepatitis B virus genes and their expression in E. coli. Nature (1979) 10.83
High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94
Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell (1981) 9.81
Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol (1984) 6.90
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (1979) 6.76
Signals regulating hepatitis B surface antigen transcription. Nature (1983) 5.02
Biology of hepatitis B virus. Science (1981) 4.93
A human hepatitis B viral enhancer element. EMBO J (1985) 3.94
Determination of RNA sequences by primer directed synthesis and sequencing of their cDNA transcripts. Methods Enzymol (1980) 3.93
Analysis of processing and polyadenylation signals of the hepatitis B virus surface antigen gene by using simian virus 40-hepatitis B virus chimeric plasmids. Mol Cell Biol (1983) 3.63
Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62
Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA. J Virol (1982) 3.51
Transcription of the hepatitis B surface antigen gene in cultured murine cells initiates within the presurface region. J Virol (1984) 3.30
Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region. J Virol (1983) 3.24
A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1983) 2.49
Site-specific base substitution and deletion mutations that enhance or suppress transcription of the SV40 major late RNA. Cell (1982) 2.32
Core and E antigen synthesis in rodent cells transformed with hepatitis B virus DNA is associated with greater than genome length viral messenger RNAs. J Mol Biol (1983) 2.20
Hybrid hepatitis B virus-host transcripts in a human hepatoma cell. Proc Natl Acad Sci U S A (1985) 1.69
Expression of hepatitis B virus surface antigen gene in cultured cells by using recombinant plasmid vectors. Mol Cell Biol (1983) 1.56
The gene S promoter of hepatitis B virus confers constitutive gene expression. Nucleic Acids Res (1983) 1.23
Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame. J Virol (1985) 1.23
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol (1993) 5.08
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
Cloning and endonuclease mapping of the hepatitis B viral genome. Nature (1979) 3.62
Characterization of Mycobacterium tuberculosis isolates from patients in Houston, Texas, by spoligotyping. J Clin Microbiol (2000) 3.38
Expression of hepatitis B viral core region in mammalian cells. Mol Cell Biol (1986) 3.14
Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci U S A (2001) 3.06
Pestivirus translation initiation occurs by internal ribosome entry. Virology (1995) 2.56
The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A (1997) 2.43
Country profile: India. Lancet (1998) 2.40
The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol (1997) 2.39
A conserved helical element is essential for internal initiation of translation of hepatitis C virus RNA. J Virol (1994) 2.35
The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity. Mol Cell Biol (1986) 2.29
Restriction endonuclease cleavage map and location of unique features of the DNA of hepatitis B virus, subtype adw2. Proc Natl Acad Sci U S A (1979) 2.15
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
In vivo phosphorylation and protein analysis of hepatitis B virus core antigen. J Virol (1987) 1.95
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol (2000) 1.93
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Expression of the hepatitis B virus X gene in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.88
Thoracoscopic implantation of cancer with a fatal outcome. Ann Thorac Surg (1995) 1.86
The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J Biol Chem (2001) 1.82
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. J Viral Hepat (2009) 1.74
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A (1995) 1.72
PSG consensus statement on management of hepatitis C virus infection--2003. J Pak Med Assoc (2004) 1.70
Expression of hepatitis B virus surface antigen gene in cultured cells by using recombinant plasmid vectors. Mol Cell Biol (1983) 1.56
An Indian strain of hepatitis E virus (HEV): cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J Clin Microbiol (1995) 1.55
trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology (1989) 1.55
Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc Natl Acad Sci U S A (1990) 1.54
Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem (2000) 1.54
Prevalence of seromarkers of HBV and HCV in health care personnel and apparently healthy blood donors. J Pak Med Assoc (1996) 1.54
Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J Virol (1999) 1.49
Ground squirrel hepatitis virus DNA: molecular cloning and comparison with hepatitis B virus DNA. J Virol (1981) 1.48
Front-line management of pulmonary tuberculosis: an analysis of tuberculosis and treatment practices in urban Sindh, Pakistan. Tuber Lung Dis (1996) 1.48
Acetaminophen metabolism and cytotoxicity in PC12 cells transfected with cytochrome P4502E1. J Mol Med (Berl) (1997) 1.47
Hepatitis E and long-term antibody status. Lancet (1993) 1.46
Monocular and binocular depth discrimination thresholds. Optom Vis Sci (1999) 1.45
The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J Virol (2000) 1.40
MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect (2001) 1.35
Vertical transmission of hepatitis E virus. Lancet (1995) 1.34
Detection of the viral sarcoma gene product in cells infected with various strains of avian sarcoma virus and of a related protein in uninfected chicken cells. J Virol (1979) 1.30
Trans-activation of HLA-DR gene by hepatitis B virus X gene product. Proc Natl Acad Sci U S A (1990) 1.22
Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol (1996) 1.21
New ways of initiating translation in eukaryotes. Mol Cell Biol (2001) 1.20
Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology (1991) 1.19
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci U S A (1996) 1.19
Functional analysis of a liver-specific enhancer of the hepatitis B virus. Proc Natl Acad Sci U S A (1991) 1.18
Interactions between nuclear factors and the hepatitis B virus enhancer. J Virol (1989) 1.16
A common structural core in the internal ribosome entry sites of picornavirus, hepatitis C virus, and pestivirus. Virus Genes (1996) 1.15
Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation. J Biol Chem (2000) 1.12
Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch Surg (1999) 1.12
Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J Med Virol (2000) 1.12
Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology (1995) 1.11
Hepatitis E virus transmission to a volunteer. Lancet (1993) 1.11
Structure and function of the hepatitis C virus internal ribosome entry site. Curr Top Microbiol Immunol (1995) 1.09
Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer. Proc Natl Acad Sci U S A (1992) 1.09
Regulation of the hepatitis B virus gene expression by the enhancer element I. Virology (1991) 1.09
Site-directed mutagenesis of the reactive center (serine 394) of antithrombin III. J Biol Chem (1988) 1.08
Regulatory mechanisms of viral hepatitis B and C. J Biosci (2003) 1.06
The hepatitis B virus enhancer modulates transcription of the hepatitis B virus surface antigen gene from an internal location. J Virol (1988) 1.04
Intrageneric transformation of neisseria gonorrhoeae and neisseria perflava to streptomycin resistance and nutritional independence. J Bacteriol (1975) 1.03
Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch Surg (1997) 1.02
Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol (1994) 1.02
T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J Viral Hepat (2007) 1.01
Retinoid X receptor alpha transactivates the hepatitis B virus enhancer 1 element by forming a heterodimeric complex with the peroxisome proliferator-activated receptor. J Virol (1995) 1.01
Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci U S A (1983) 0.99
Rapid plate method for the isolation of lysogenic bacteriophages. Appl Microbiol (1974) 0.98
A patient with persistent wheezing, sinusitis, elevated IgE, and eosinophilia. Ann Allergy Asthma Immunol (1999) 0.97
Direct detection of hepatitis B virus from dried blood spots by polymerase chain reaction amplification. J Clin Microbiol (1992) 0.96
Hepatitis B virus X protein produced in Escherichia coli is biologically functional. J Virol (1990) 0.96
Isolation of a novel human voltage-dependent anion channel gene. Eur J Hum Genet (1998) 0.95
Indian hepatitis E virus shows a major deletion in the small open reading frame. Virology (1992) 0.95
Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels. Mol Psychiatry (2011) 0.94
Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein. J Virol (2001) 0.94
A rational approach to the radiologic evaluation of children with Wilms' tumor. Cancer (1982) 0.94
Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways. Exp Mol Med (1999) 0.92
Evaluating the mobility of toxic metals in untreated industrial wastewater sludge using a BCR sequential extraction procedure and a leaching test. Anal Bioanal Chem (2005) 0.92
IL-1 beta production in cultured human monocytes is regulated at multiple levels. J Immunol (1989) 0.92
The hepatitis B virus transactivator protein, HBx, interacts with single-stranded DNA (ssDNA). Biochemical characterizations of the HBx-ssDNA interactions. J Biol Chem (1996) 0.91
Demonstration of a competence-enhancing factor in supernatants of Neisseria gonorrhoeae F62 type T1. Biochem Biophys Res Commun (1975) 0.91
Effector T cells immune reactivity among patients with acute hepatitis E. J Viral Hepat (2011) 0.91
The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS. Ann Neurol (1999) 0.90
Negative regulation of the hepatitis B virus pre-S1 promoter by internal DNA sequences. Virology (1989) 0.89
Purification and properties of rat liver nuclear proteins that interact with the hepatitis B virus enhancer 1. J Biol Chem (1996) 0.88
Detection of the negative strand of hepatitis E virus RNA in the livers of experimentally infected rhesus monkeys: evidence for viral replication. J Med Virol (1994) 0.88
Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism. J Viral Hepat (2011) 0.88
Viral RNA but no evidence of replication can be detected in the peripheral blood mononuclear cells of hepatitis E virus-infected patients. J Viral Hepat (2010) 0.87
Direct detection of hepatitis C virus RNA in serum by reverse transcription PCR. Biotechniques (1993) 0.87
Hepatitis B virus X protein partially substitutes for E1A transcriptional function during adenovirus infection. Virology (1996) 0.86
Magnetic resonance imaging of bone marrow disease in children. Radiology (1984) 0.86
A novel mutation in the mitochondrial tRNA(TYr) gene associated with exercise intolerance. Neurology (2000) 0.86
Modification of the active site of isocitrate lyase from watermelon cotyledons. Arch Biochem Biophys (1985) 0.85